<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02294877</url>
  </required_header>
  <id_info>
    <org_study_id>110-504</org_study_id>
    <nct_id>NCT02294877</nct_id>
  </id_info>
  <brief_title>A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)</brief_title>
  <acronym>MARS</acronym>
  <official_title>A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioMarin Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ICON plc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>BioMarin Pharmaceutical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this program are: to characterize and describe the Mucopolysaccharidosis IV
      type A (MPS IVA) population as a whole, including the heterogeneity, progression, and natural
      history of MPS IVA; to evaluate the long-term effectiveness and safety of Vimizim®,
      including, but not limited to, the occurrence of serious hypersensitivity reactions,
      anaphylaxis, and changes in antibody status; to help the medical community with the
      development of recommendations for monitoring MPS IVA patients and reports on patient
      outcomes to optimize patient care; to collect data on other treatment paradigms, and evaluate
      the prevalences of their use and their effectiveness; to characterize the effects and safety
      of Vimizim treatment 5 years from enrollment in the Registry for patients under 5 years of
      age; to monitor pregnancy exposure, including maternal, neonatal, and infant outcomes; and to
      monitor patients who have completed the MOR-005 and MOR-007 clinical trials. These patients
      will be encouraged to enroll in the applicable Registry Substudy and will be monitored using
      the MOR-005 and MOR-007 assessment schedules, respectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MARS is a multicenter, multinational, observational disease registry for patients diagnosed
      with Mucopolysaccharidosis Type IVA (MPS IVA). The Registry will collect medical history, and
      clinical and safety assessments every six months, for up to 10 years. The Registry will
      enroll and collect data on patients over a period of at least 8 years from the time of the
      first marketing approval globally and data on individual patients will continue to be
      collected for at least 2 years from the time the last patient was enrolled or until the
      Registry is completed.

      These assessments are designed to further characterize the spectrum of clinical signs and
      symptoms of the disease, and to further characterize the safety profile of Vimizim in a
      broader population. It is not required that patients receive Vimizim to be eligible to
      participate in this Registry.

      In addition, this Registry will collect additional data on patients who have completed the
      MOR-005 and MOR-007 clinical trials. The MOR-005 and MOR-007 clinical trial patients will be
      enrolled into the appropriate Registry Substudy for a minimum of 5 years from the time of the
      patient's enrollment in the MOR-005 clinical study or MOR-007 clinical study. After the 5
      year period, these patients should remain in MARS until the Registry is complete.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Safety of Vimizim treated patients as measured by the incidences of Adverse Events, Serious Adverse Events, and immunology tests</measure>
    <time_frame>10 Years</time_frame>
    <description>Additional safety measures are medications, occurrence of Bone Marrow Transplant/Hematopoietic Stem Cell Transplant, clinical laboratory tests, vital signs, Electrocardiograms, Echocardiograms, immunogenicity results, physical examinations, imaging studies, and cervical spine imaging.
All assessments in this observational study will be carried out per the participating institution's standard of care.
The MARS Annual report will descriptively summarize the safety and outcome measurements for the duration of this voluntary, observational study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of Vimizim as measured by the 6MWT, 3MSCT, RFTs, FEV1, FIVC, FVC, and MVV</measure>
    <time_frame>10 years</time_frame>
    <description>Efficacy of Vimizim as measured by the changes in the 6 minute walk test (6MWT), 3 minute stir climb test (3MSCT), respiratory function tests (RFTs) including forced expiratory volume for 1 second (FEV1), forced inspiratory vital capacity (FIVC), forced vital capacity (FVC), and maximum voluntary ventilation (MVV) and by urinary Keratan Sulfate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The MARS Pregnancy Substudy will collect safety data measured by Adverse Events, Serious Adverse Events, immunology tests, and the infant outcomes as measured by a live birth</measure>
    <time_frame>10 years</time_frame>
    <description>The MARS Pregnancy Substudy will collect safety data on the outcomes of pregnancy in women who receive Vimizim as measured by Adverse Events, Serious Adverse Events, immunology tests, and the infant outcomes as measured by a live birth.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">583</enrollment>
  <condition>Mucopolysaccharidosis IV Type A</condition>
  <condition>Morquio A Syndrome</condition>
  <condition>MPS IVA</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vimizim® (elosulfase alfa)</intervention_name>
    <description>Recombinant human N acetylgalactosamine 6 sulfatase (rhGALNS)</description>
    <other_name>BMN 110</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood serum; urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with MPS IVA disease and patients treated with Vimizim, although patients are not
        required to receive Vimizim to be eligible to participate in this Registry.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients eligible to participate in this Registry must meet all of the following criteria:

          -  Diagnosed with MPS IVA as confirmed by either N-acetylgalactosamine 6-sulfatase
             (GALNS) enzymatic test or by a diagnostic molecular test

          -  Willing and able to provide written, signed informed consent, or, in the case of
             patients age &lt; 18 years, provide written assent (if required) and written informed
             consent, signed by a legally authorized representative after the nature of the
             Registry has been explained and prior to performance of any Registry-related
             procedures

          -  Willing to undergo assessments to establish baseline data or permit Investigator to
             enter assessment data recorded prior to Registry entry if available in the patient's
             medical records. Entry assessments may include: demographics, medical history, urinary
             keratan sulfate level, urinary protein level, immunogenicity testing, vital signs,
             physical examination, and height and weight

        Patients eligible to participate in the Registry Substudy for MOR-005 must meet all of the
        following criteria:

          -  Must have completed the MOR-005 clinical trial

          -  Willing and able to provide written, signed informed consent, or, in the case of
             patients age &lt; 18 years, provide written assent (if required) and written informed
             consent by a legally authorized representative after the nature of the Registry
             Substudy has been explained and prior to any Registry-related Substudy procedures

          -  Willing to permit Investigator to enter assessment data recorded prior to Registry

          -  Substudy entry if available in the patient's medical records

        Patients eligible to participate in this Registry Substudy for MOR-007 must meet all of the
        following criteria:

          -  Must have completed the MOR-007 clinical trial

          -  Willing and able to provide written, signed informed consent, or in the case of
             patients age &lt; 18 years, provide written assent (if required) and written informed
             consent by a legally authorized representative after the nature of the Registry
             Substudy has been explained, and prior to any Registry-related Substudy procedures

          -  Willing to permit Investigator to enter assessment data recorded prior to Registry
             Substudy entry if available in the patient's medical records

        Exclusion Criteria:

        Patients who meet the following exclusion criterion will not be eligible to participate in
        the Registry or Registry Substudies:

        • Patients currently participating in a BMN 110 (elosulfase alfa) clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Affairs</last_name>
    <role>Study Director</role>
    <affiliation>Study Management</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MEDINFO</last_name>
    <phone>615-523-0310</phone>
    <email>MEDINFO@bmrn.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>BioMarin</last_name>
    <phone>415-506-6700</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Goode</last_name>
      <phone>501-364-3120</phone>
      <email>goodega@archildrens.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Burrow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth A Sellars, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Moseley, MS, RD</last_name>
      <phone>323-226-3816</phone>
      <email>kmoseley@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Maria Ramirez</last_name>
      <phone>323-409-6800</phone>
      <email>mramirez@dhs.lacounty.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Shoji Yano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nina Movsesyan, Phd</last_name>
      <phone>714-509-3008</phone>
      <email>nmovsesyan@choc.org</email>
    </contact>
    <investigator>
      <last_name>Raymond Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Chang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.I. Dupont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Davey</last_name>
      <phone>302-651-5916</phone>
      <email>LDavey@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Michael Bober, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Mackenzie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Colleen Ditro, APN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela Duker</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's National Health System</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Crosby, CGC</last_name>
      <phone>202-476-6812</phone>
      <email>kacrosby@childrensnational.org</email>
    </contact>
    <investigator>
      <last_name>Pranoot Tanpaiboon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miami Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelin Janvier</last_name>
      <phone>786-624-3534</phone>
      <email>michelin.janvier@mch.com</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Rodriguez Paez</last_name>
      <phone>786-268-1741</phone>
      <email>claudia.rodriguezpaez@mch.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mislen Bauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Cagle</last_name>
      <phone>404-778-8618</phone>
      <email>scagle@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Sablon</last_name>
      <email>esablon@emory.edu</email>
    </contact_backup>
    <investigator>
      <last_name>William Wilcox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kapiolani Medical Center for Women and Children</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Micah Tong</last_name>
      <phone>808-983-6427</phone>
      <email>micah.tong@hawaiipacifichealth.org</email>
    </contact>
    <investigator>
      <last_name>Robert Wallerstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michah Tong, CCRP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JoAnn Cheung, MA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Katz, MS</last_name>
      <phone>312-227-6764</phone>
      <email>rkatz@luriechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Barbara Burton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel Charrow, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lauren Hitchens, APN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erika Vucko, APN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shanna Widera, APN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville Research Foundation Inc. - Kosair Charities Pediatric Clinical Research Unit</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Penny</last_name>
      <phone>502-629-2721</phone>
      <email>slpenn03@louisville.edu</email>
    </contact>
    <contact_backup>
      <last_name>Molly Harper</last_name>
      <phone>502-629-7447</phone>
      <email>molly.harper@louisville.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alexander Asamoah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janice Sullivan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kara Goodin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyla Almedia</last_name>
      <phone>857-218-4636</phone>
      <email>kyla.almeida@childrens.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Abra Roberts</last_name>
      <phone>617-919-2536</phone>
      <email>abra.roberts@childrens.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Amy Kritzer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olaf Bodamer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leah Hecht</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyla Almeida</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Abra Roberts</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vera Anastasoaie</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Childrens Hospitals and Clinics of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alissa Jorgenson</last_name>
      <phone>612-813-6922</phone>
      <email>alissa.jorgenson@childrensmn.org</email>
    </contact>
    <investigator>
      <last_name>Vikas Bhambani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nancy J. Mendelsohn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rebecca Olson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Specialty Center of Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Crosier</last_name>
      <phone>702-862-1136</phone>
      <email>dcrosier@cure4thekids.org</email>
    </contact>
    <investigator>
      <last_name>Angela Berg, DNP</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ayyanar Kanyalakshmi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arlene Bayreder, MSN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alan Ikeda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>McKenzie Karelus, DPT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicola Longo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nik Farhana Nik Abdul Rashid, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU-Langone Medical Center School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marissa Ferraris</last_name>
      <phone>212-263-0139</phone>
      <email>Marissa.Ferraris@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Heather Lau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zahra Bakhtiar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marissa Ferraris, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danika Anganoo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michele Ford</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crista Walters</last_name>
      <phone>919-681-1945</phone>
      <email>crista.walters@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Priya Kishnani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Genevieve Nesom</last_name>
      <phone>267-426-1368</phone>
      <email>nesomg@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Lynne Ierardi-Curto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadene Henderson</last_name>
      <phone>412-692-6065</phone>
      <email>nadene.henderson@chp.edu</email>
    </contact>
    <investigator>
      <last_name>Damara Ortiz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Areeg El-Gharbawy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gerard Vockley, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nadene Henderson, MS, LCGC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of the King's Daughters</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corina Moorehead</last_name>
      <phone>757-401-1132</phone>
      <email>acmoorehead@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Carrie E Mishoe</last_name>
      <phone>304-942-2234</phone>
    </contact_backup>
    <investigator>
      <last_name>Samantha A Vergano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erin McAndrews, LPN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Parrott, LPN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98145-5005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linnea Brody</last_name>
      <phone>206-884-1264</phone>
      <email>linnea.brody@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Angela Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Klane White, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Hale, MN, ARNP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cassie Bird</last_name>
      <phone>414-266-3072</phone>
      <email>cbird@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Donald Basel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Offord</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Rhead, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Graz</name>
      <address>
        <city>Graz</city>
        <zip>A-8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michaela Brunner-Krainz, MD</last_name>
      <phone>43-316-385-2813</phone>
      <email>michaela.brunner@klinikum-graz.at</email>
    </contact>
    <investigator>
      <last_name>Michaela Brunner-Krainz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte de Gier</last_name>
      <email>charlotte.degier@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Vassiliki Konstantopoulo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dorothea Moeslinger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tine Maes</last_name>
      <phone>0032(0)318214155</phone>
      <email>tine.maes@uaz.be</email>
    </contact>
    <investigator>
      <last_name>Francois Eyskens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's &amp; Women's Centre of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V52 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Thomas</last_name>
      <phone>604-875-3806</phone>
      <email>athomas2@cw.bc.ca</email>
    </contact>
    <investigator>
      <last_name>Lorne Clarke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvia Stockler-Ispiroglu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Sirrs, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sainte-Justine Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabiola Breault</last_name>
      <phone>514-345-4931</phone>
      <phone_ext>2774</phone_ext>
      <email>fabiola.breault@reserche-ste-justine.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Phillipe Campeau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Pepin</last_name>
      <phone>514-9341934</phone>
      <phone_ext>23737</phone_ext>
      <email>sandra.pepin@muhc.mcgill.ca</email>
    </contact>
    <contact_backup>
      <last_name>Hasmig Kavoukian</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>35661</phone_ext>
      <email>hasmig.kavoukian@muhc.mcgill.ca</email>
    </contact_backup>
    <investigator>
      <last_name>John Mitchell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francide Lapointe</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>12802</phone_ext>
      <email>flapointe.chus@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Bruno Maranda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastien Levesque, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinika Dětského a Dorostového Lékařstvi</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Zeman</last_name>
      <phone>22496 7777</phone>
    </contact>
    <investigator>
      <last_name>Martin Magner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiri Zeman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Copenhagen University Hospital, Klinik For Sjaeldne Handicap</name>
      <address>
        <city>Copenhagen</city>
        <state>Dk-2100</state>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sannie Mahncke</last_name>
      <phone>+45 23866095</phone>
      <email>sannie.mahncke@region.dk</email>
    </contact>
    <investigator>
      <last_name>Christine Dali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron Cedex</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Chatagnat</last_name>
      <phone>+33472129541</phone>
      <email>nicole.chatagnat@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Nathalie Reyes</last_name>
      <phone>+33 4 72 12 95 41</phone>
    </contact_backup>
    <investigator>
      <last_name>Nathalie Guffon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Study Center, University Pediatric Clinic</name>
      <address>
        <city>Bochum</city>
        <zip>4791</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Boeger</last_name>
      <phone>0234-509-2809</phone>
      <email>s.boeger@klinikum-Bochum.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Lücke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Muschol, MD</last_name>
      <phone>+49-40-7410-49321</phone>
      <email>muschol@uke.uni-hamburg.de</email>
    </contact>
    <investigator>
      <last_name>Nicole Muschol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zentrum für seltene Erkrankungen, Horst-Schmidt-Kliniken</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurizio Scarpa</last_name>
      <phone>0611-43-2314</phone>
      <email>Maurizio.scarpa@hsk-wiesbaden.de</email>
    </contact>
    <investigator>
      <last_name>Christina Lampe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple Street Children's University Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eithne Losty</last_name>
      <phone>01 8921903</phone>
      <email>eithne.losty@cuh.ie</email>
    </contact>
    <investigator>
      <last_name>Ardeshir Ahmad Monavari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ellen Crushell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ina Knerr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joanne Hughes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Policlinico Vittorio Emanuele, presidio G Rodolico, Università di Catania</name>
      <address>
        <city>Catania</city>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agata Fiumara, MD</last_name>
      <phone>3900953782478</phone>
    </contact>
    <investigator>
      <last_name>Agata Fiumara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Viviana Brafa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annarita Pittala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federica Raudino, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Meyer</name>
      <address>
        <city>Firenze</city>
        <zip>50132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Donati, MD</last_name>
      <phone>0039 055 5662482</phone>
      <email>m.donati@meyer.it</email>
    </contact>
    <investigator>
      <last_name>Alice Donati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Procopio, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero San Gerardo di Monza</name>
      <address>
        <city>Monza</city>
        <zip>20090</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giusi Sgroi</last_name>
      <phone>390392334915</phone>
      <phone_ext>3525</phone_ext>
      <email>gsgroi@fondazionembbm.it</email>
    </contact>
    <investigator>
      <last_name>Rossella Parini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cinzia Galimberti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Serena Gasperini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emanuela Marrocco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Serena Motto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Rigoldo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefania Sala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federico II University Hospital</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Coppola</last_name>
      <email>emma.coppola@studenti.unina.it</email>
    </contact>
    <investigator>
      <last_name>Roberto Della Casa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simona Fecarotta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Kuala Lumpur</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siti Nuradila Bt Muhamad</last_name>
      <phone>+60-326155555</phone>
      <phone_ext>7062</phone_ext>
      <email>lutfan_aakif@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Mohamed Ali Noraishah</last_name>
      <email>dr_aishah@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ngu Hock Lock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hui Bein Chew</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Huey Yin Leong</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Malay Medical Center</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gim Sim</last_name>
      <email>ooigimsim@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Thong Meow-Keong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Premala Muthukumarasamy</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frits Wijburg, MD</last_name>
      <phone>31 20 5662303</phone>
      <email>f.a.wijburg@amc.nl</email>
    </contact>
    <investigator>
      <last_name>Frits Wijburg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rotterdam University Hospital Medical Centre</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 GE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Hardon</last_name>
      <phone>+31 0 107037047</phone>
      <email>j.hardon@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Ana Van der Ploeg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children Memorial Health Institute</name>
      <address>
        <city>Warszawa</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Tylki-Szymanska, MD</last_name>
      <phone>48 22 815-7584</phone>
      <email>a.tylki@czd.pl</email>
    </contact>
    <investigator>
      <last_name>Anna Tylki-Szymanska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Pediátrico de Coimbra (Centro Hospitalar de Coimbra)</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-062</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Garcia, MD</last_name>
      <phone>+351 239 239 488 700</phone>
      <email>pg@chuc.min-saude.pt</email>
    </contact>
    <investigator>
      <last_name>Paula Garcia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luisa Diogo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Lisboa Norte</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diogo Nuno Fonseca da Cruz, MD</last_name>
      <email>diogocruz@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Diogo Nuno Fonseca da Cruz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricio Ricardo da Terra Aguiar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Lisboa Centro - Hospital de Dona Estefânia</name>
      <address>
        <city>Lisbon</city>
        <zip>1169-045</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Sequeira, MD</last_name>
      <phone>+351 21 312 68 94</phone>
      <email>silviasequeira@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Silvia Sequeira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Cristina Ferreira, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Jorge Children's Hospital, Centro de Investigaciones Clinicas</name>
      <address>
        <city>San Juan</city>
        <zip>00912</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heriberto Roman-Berrios</last_name>
      <phone>787-999-9453</phone>
      <email>heriberto.roman@sanjorgechildrenshospital.com</email>
    </contact>
    <contact_backup>
      <last_name>Mirta Fernandez</last_name>
      <phone>787-999-9453</phone>
      <email>mirta.fernandez@sanjorgechildrenshospital.com</email>
    </contact_backup>
    <investigator>
      <last_name>Juan A Santiago-Cornier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Belfast City Hospital</name>
      <address>
        <city>Belfast</city>
        <zip>BT9 7AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Murphy</last_name>
      <phone>02890636366</phone>
      <email>alison.murphy@belfasttrust.hscni.net</email>
    </contact>
    <investigator>
      <last_name>Fiona Stewart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Birmingham - Selly Oaks</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2WB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaun Bolton</last_name>
      <phone>44121-371-6795</phone>
      <email>shaun.bolton@uhb.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Vishy Veeranna, MD</last_name>
      <phone>+44 0 121 371 6985</phone>
      <email>vishy.veeranna@uhb.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Tarekegn G Hiwot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte Dawson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Birmingham Children's Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B4 6NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Stewart</last_name>
      <phone>0121 333 9907</phone>
      <email>Alice.stewart@bch.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Alison Berry</last_name>
      <phone>+0121-333-9962</phone>
      <email>Alison.Berry@bch.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Saikat Santra, MA/MB/BCh</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suresh Vijayaraghavan, MB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Free NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Lansdell</last_name>
      <phone>020-7794-0500</phone>
      <phone_ext>33476</phone_ext>
      <email>erika.lansdell@nihr.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Derralynn Hughes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Uma Ramaswami, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Atulkumar Mehta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Hospital for Neurology and Neurosurgery</name>
      <address>
        <city>London</city>
        <zip>WC1N 3BG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Amado Fondo</last_name>
      <email>AnaAmado.Fondo@uclh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Elaine Murphy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robin Lachmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>WC1N 6NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Hamida</last_name>
      <phone>0207-405-9200</phone>
      <phone_ext>6894</phone_ext>
      <email>hamida.ali@gosh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Maureen Cleary, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Crowther</last_name>
      <phone>+44 161 701 9137</phone>
      <email>elisabeth.jameson@cmft.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Niamh Finnigan</last_name>
      <phone>+44 161 701 9259</phone>
      <email>niamh.finnigan@cmft.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Elisabeth Jameson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Jones, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Broomfield, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Salford Royal NHS Foundation Trust</name>
      <address>
        <city>Salford</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Meehan</last_name>
      <phone>0161 206 4192</phone>
      <email>marie.meehan@srft.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Christian Hendriksz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Reena Sharma, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gisela Wilcox, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Jovanovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Puerto Rico</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2014</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2014</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucopolysaccharidoses</mesh_term>
    <mesh_term>Mucopolysaccharidosis IV</mesh_term>
    <mesh_term>Osteochondrodysplasias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

